Scholarly Index
Nancy E. Kemeny
Memorial Sloan Kettering Cancer Center; 36,021 total citations; 462 total publications; best world rank #26
Memorial Sloan Kettering Cancer Center
36,021Total citations
462Total publications
97H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 26 | US 13 | 99.85 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 28 | US 20 | 99.76 |
| Colorectal Cancer Treatments and Studies | Lifetime | 35 | US 19 | 99.80 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 120 | US 71 | 99.56 |
| Colorectal and Anal Carcinomas | Lifetime | 93 | US 52 | 99.10 |
| Genetic factors in colorectal cancer | Lifetime | 222 | US 113 | 98.99 |
| Cancer Treatment and Pharmacology | Lifetime | 288 | US 160 | 99.13 |
| Multiple and Secondary Primary Cancers | Lifetime | 175 | US 76 | 97.95 |
| Gastric Cancer Management and Outcomes | Lifetime | 773 | US 241 | 98.48 |
| Neutropenia and Cancer Infections | Lifetime | 711 | US 304 | 94.57 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 907 | US 364 | 87.48 |
| Chemotherapy-related skin toxicity | Lifetime | 684 | US 314 | 83.53 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 978 | US 168 | 91.04 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 846 | US 138 | 88.97 |